Tobramycin (asTobramycin sulfate) 3 mg/ml
Dexamethasone phosphate (as
dexamethasone sodium phosphate) 1 mg/ml
Ampoule 0.4ml, 1ml
 

Single-dose ophthalmic

Prevention and treatment of inflammation and prevention of infection associated with cataract surgery in adults and children aged 2 years and older.

Adults:

One drop instilled into the conjunctival sac(s) every 4 to 6 hours while the patient is awake. During the initial 24 to 48 hours, the dosage may be increased to one drop every two hours while the patient is awake. Dosing should continue for 14 days not to exceed a maximum of 24 days. Frequency should be decreased gradually as warranted by improvement in clinical signs. Care should be taken not to discontinue therapy prematurely.

Use in the Elderly:

Clinical studies have indicated dosage modifications are not required for use in the elderly.

Paediatric population:

Drug may be used in children 2 years of age and older at the same dose as in adults.